This document discusses urinary tract infections (UTIs) and related topics. It begins by describing pyelonephritis, an ascending urinary tract infection that reaches the kidneys. It then covers the signs, symptoms, and laboratory findings of acute pyelonephritis. Chronic pyelonephritis is also discussed. Additional sections cover night sweats, tuberculosis, referred pain, urine analysis, and hematuria.
Tuberculosis is an infectious disease. In this presentation shortly information has been extracted from text books of Medicine and Bangladesh National Guidelines of Tuberculosis (4th & 5th edition). here drugs, FDC and effects have been reviewed also.
This presentation focuses on the entity known as pyrexia of unknown origin / fever of unknown origin. It demonstrates both common and rare causes, and the epidemiological trend, its clinical presentation, management and prognosis.
Tuberculosis is an infectious disease. In this presentation shortly information has been extracted from text books of Medicine and Bangladesh National Guidelines of Tuberculosis (4th & 5th edition). here drugs, FDC and effects have been reviewed also.
This presentation focuses on the entity known as pyrexia of unknown origin / fever of unknown origin. It demonstrates both common and rare causes, and the epidemiological trend, its clinical presentation, management and prognosis.
Hypersensitivity pneumonitis and pulmonary eosinophilia syndromesdocaneesh
an inflammatory disorder of the lung involving alveolar walls and terminal airways that is induced by repeated inhalation of a variety of organic agents in a susceptible host
Rational Drug use - Group 5 presentation 2.0 bello editCipriano Bello
The slide is about rational use of drugs, what influences it, factors and reasons, strategies to improve them, and choosing an intervention (WHO priorities).
Hypersensitivity pneumonitis and pulmonary eosinophilia syndromesdocaneesh
an inflammatory disorder of the lung involving alveolar walls and terminal airways that is induced by repeated inhalation of a variety of organic agents in a susceptible host
Rational Drug use - Group 5 presentation 2.0 bello editCipriano Bello
The slide is about rational use of drugs, what influences it, factors and reasons, strategies to improve them, and choosing an intervention (WHO priorities).
A case presentation and discussion of TB Meningitis presented in a Tertiary Care Hospital ER. Includes presenting complaints, work-up, diagnosis and relevant case discussion.
Hydatid cysts are most commonly found in the liver and lungs, although they may also occur in other organs, bones and muscles. The cysts can increase in size to 5 – 10 cm or more and may survive for decades. Non-specific signs include loss of appetite, weight loss and weakness
Echinococcus granulosus sensu lato occurs practically worldwide, and more frequently in rural, grazing areas where dogs ingest organs from
diagnosis
epidemiology
managment
This Part 1 of 'Monsoon Illnesses affecting Lungs' covers an overview of leptospirosis, malaria and dengue. It base on Harrison's Textbook of Internal Medicine, 18th edition.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Urinary Tract Infections
1. Case 2 - UTI
1 | P a g e
Pyelonephritis
o Ascending urinary tract infection
Reaches Pyelum of kidney
o Dividing into: A) Acute Pyelonephritis B) Chronic Pyelonephritis
Acute pyelonephritis (APN)
Epidemiology:
i. More common in women than men
o Women have a short urethra
Risk Factors:
i. Urinary Tract Obstruction
ii. Medularry Sponge kidney
iii. Diabetes mellitus
iv. Preganancy
v. Sickle cell trait/disease
Pathogenesis:
i. Vesicoureteral reflux (VUR) with ascending infection
o Intravesical portion of the ureter is normally
compressed with micturition
Prevents reflux of urine into the uterus
o In VUR, the intravesical portion of the ureter is not
compressed during micturition
Urine refluxes into the ureters
ii. Ascending Infection:
o Most common mechanism for UTI in females
o Distal urethra and vaginal introitus are normally
colonised by E. Coli
o Oragnisms ascend into urethra and bladder
Causes urethritis and cystitis
o If VUR is present, infected urine ascends to the renal
pelvis and renal parenchyma
Causes APN
2. Case 2 - UTI
2 | P a g e
Gross and microscopic findings:
i. Greyish white areas of abscess formation are in the cortex +
medulla
ii. Microabscess formation occurs in the tubular lumens and
intersstitium (Shown below)
Clinical Findings:
i. Spiking fever, flank pain
ii. Increased frequency of urination
iii. Painful urination (dysuria)
Laboratory findings:
i. WBC casts (key fidning)
ii. Pyuria
iii. Bacteriuria (usually E. Coli)
iv. Haematuria
Complications:
i. Chronic pyelonephritis
ii. Perinephric abscess
iii. Renal Paillary necrosis
iv. Septicemia with endotoxic shock
3. Case 2 - UTI
3 | P a g e
Chronic Pyelonephritis (CPN)
Pathogensis:
i. VUR starting in young girls
ii. Lower urinary tract obstruction
o Produces hydronephrosis
o Example:
Prostatic hyperplasia
Renal stones
Gross and microscopic findings:
i. Reflux type of CPN
o U-shaped cortical scars
overlying a blunt calyx
o Visible with
an intravenous pyelogram (IVP)
ii. Obstruction type CPN
o Uniform dilation of the calyces
o Diffuse thinning of cortical tissues
iii. Microscopic findings
o Chronic inflammation
Secondary scarring of the glomeruli
o Tubular atrophy
Tubules contain:
Eosinophilic material
o Resemble thyroid tissue
‘’Thyroidization’’
Note here the changes we call
"thyroidization." You will see many
chronic inflammatory cells in the
interstitial tissue and dilated tubules
containing pink staining proteinaceous
goo, giving the appearance of thyroid
colloid. You should note the scarring in
the interstitial tissue in general and to
some degree around the glomeruli.
This is often associated with chronic
ischemic injury of the kidney, which
worsens as the process proceeds.
Think diabetes and hypertension.
Reference:
http://medsci.indiana.edu/c602web/602/
c602web/renal/slide79.htm
Clinical and laboratory findings
4. Case 2 - UTI
4 | P a g e
i. History of recurrent APN
ii. May cause hypertension
o Reflux nephropathy is a cause of hypertension in
children
iii. May cause Chronic Renal Failure (CFR)
Night Sweats:
o There is no good evidence based diagnosis answer
Due to the following:
i. Limited number of studies on subjects with such ailment
ii. No clinical trial have directly studied symptomatic relief of
night sweats alone
iii. History taking is the best initial diagnostic tool ( Strength of
recommendation (SOR): C, based on usual practice and clinical
opinion)
Very common complaint for:
i. Menopausal women with hot flashes
ii. Most common age group in both genders (41-55 years)
iii. Common causes not widely studies, mainly attributed to
lymphoma, TUBERCOLOSIS, and HIV infection.
o Not common in outpatient care!
iv. Medications, such as:
o Antidepressant (SSRIs, Venlafaxine... etc.)
o Antimigranes
o Antipyretics (Aspirin, acetaminophen, and NSAIDS)
o Cholinergic agonists
o GNRH agonists
o Hypoglycaemic agents
o Sympathomimetic agents
o Others, alcohol, beta blockers, and calcium channel
blockers to name a few!
Differential diagnosis:
5. Case 2 - UTI
5 | P a g e
Tuberculosis (TB)
o Epidemiology and pathophysiology:
Contracted by inhalation of Myobacterium tuberculosis
Characteristics:
i. Strict aerobe, acid fast (due to mycolic acid in cell wall)
Screening:
i. Purified Protein derivative (PPD) intradermal skin test
o Does NOT distinguish active from inactive disease
Primary TB:
i. Subpleural location
o Upper part of the lower lobes or lower part of the upper
lobes
ii. Usually resolves
o Produces a calcified granuloma or area of scar tissue
o May be a nidus for secondary TB
Secondary (reactivation) TB:
i. Due to reactivation of a previous primary TB site
ii. Invovles one or both apices in upper lobes of respiratory lung
6. Case 2 - UTI
o Ventilation (oxygenation) is greatest in the upper lobes
o Decrease incidence of TB in mountain people
Used to be previous treatment before advent of
6 | P a g e
strong antibiotics
Increased antibiotics resistance M. TB
strains brought back mountain less
oxygenation regimen
o Cavitary lesion due to release of cytokines from
memory T Cells
iii. Clinical findings:
o Fever
o Drenching night sweats
o Weight loss
iv. Complications:
o Miliary spread in lungs due to invasion into the
bronchus or lymphatics
o Miliary spread to extrapulmonary sites
Due to invasion of pulmonary vein tributaries
Kidney is the most common extrapulmonary site
Also called: tuberculosis cutis acuta
generalisata
o Massive hemoptysis
o Bronchietctasis
o Scar carcinoma
o Granulomatous hepatitis
o Spread to vertebra (Pott’s disease)
Referred Pain:
7. Case 2 - UTI
o Pain originating in a visceral structure may be referred to and felt in a somatic
7 | P a g e
structure
o Several proposed theories in explaining its mechanism
i. Convergence – projection theory of visceral pain
o Suggest that two different afferent segments terminate
at the same spinal cord level and end there.
o Converging nociceptive inputs into same synaptic
interneuron or second order neuron
o Transmitted to higher brain centers through the same
dorsal horn and intermediate grey matter
ii. Concept of referred pain
o Second order GSA are continuously being activated by
GVA first order neurons
o Thereby, lowering threshold of stimulation of 2nd order
neurons
o Nociceptive inputs is relayed to its somesthetic cortex
o It normally receives normally somatic information from
other areas, such as upper limb
o The brain interprets such information as if it was
coming from somewhere else
o Thus, it’s a problem of the terminal end (i.e.,
somatosensory cortex) that interprets the signals not the
stimulus or receptor that establish localisation of such
sensations
None Proven to be true!!!
o Still unknown
o Expanded interest in research after World War II
Due to
i. Generalised painful sensations from phantom limb pain of
soldiers
ii. Increased incidence of myocardial infarcts with the blooming
economic prosperity
o Been known as early as 1880’s
o Best example: Angina pectori
i. Pain sensation arising in heart muscle
ii. Experience as pressure in chest, back , arm
iii. All from regions served by the same segmental spinal nerve
o Can be manifested as a toothache, and neck pain
Due to same embryological loci derivation
Patients may visit a dentist, but they
have underlying heart problems
GO TO A CARDIOLOGIST!!!
o Other areas (related to the case):
i. Suprapubic pain: Prostate hyperplasia
8. Case 2 - UTI
8 | P a g e
ii. left flank tenderness : pylonephrititis
Urine analysis:
o Gold standard in initial work up of kidney function
A diagnostic tool
i. Ordered at intervals as a rapid method
o Helps monitor organ’s
Function
Status
Response to treatment
ii. Commonly ordered due to UTI’s symptomps:
o Abdominal pain
o Back pain
o Dysuria, or frequet urination
o Haematuria
iii. Can be useful in monitoring certain conditions
o Interpretation of the results:
i. Visual examination:
o Urine colour, clarity, and concentration
Normal: shades of yellow
From very pale to dark amber
9. Case 2 - UTI
9 | P a g e
o Sometimes blood can contaminate it
Due to
haemorroids
Woman’s mensturation
Other causes (many pathologic)
o Depth of urine:
Crude indicator of its concentration
Pale yellow or colourless
Diluted urine (aka, water loss)
Dark yellow
Concentrated highly osmotic urine
o Seen In first morning urine
o With dehydration
o Or during a fever
o Clarity
Different termss:
Clear
Slighly cloudy
Cloudy
Turbid
Normal: clear or cloudy
Substances can cause cloudy urine
o Prostatic fluid
o Sperm
o Mucous
o Cells from skin
o Normal urine crystals
Or Bacteria needs attention!!
ii. Chemical examination:
o Using prepared test strips
Normal plastic strips holding small squares of
test pads paper
They absorb urine once dippped
Chemical reactionoccurs
Pad colour changes within seconds to
minutes
Timing is important in diagnosis
May result in errors
o Best use automated instruments
to read
Change of colour approximated amount of
existing substance
Example:
10. Case 2 - UTI
o Slight color – small [protein]
o Dark color - large [protein]
10 | P a g e
o Frequent chemical tests:
Specific Gravity:
Indicates urine concentration
o No abnormal values
Comparison between dissoloved
substances and water
Test pad
o Upper limit (1.035)
o Lower limit (1.002)
Underlying causes:
o Lack of concentration and
dilution (e.g., CRF)
o First sign of intrinsic renal
disease
pH:
No abornamal values
Indicates acidic or alkaline pH
Determined by:
o Diet
- Low carb diet = Alkaline
- High protein diet = Acidic
o Proteus infection:
Alkaline urine, urease
converts urea into
ammonia
Can cause crystals due to acidity or
alkalinity
o Crystals forming in kidney, are
called ‘’calculus’’
Protein:
Elevated in urine, proteinuria
o Early sign of kidney disease
o Normal, little or no protein
Detects albumin (not globulins)
SSA: detects albumin and globulins
Albuminuria: dipstick and SSA have
same results
Disorders that cause it:
o That can cause high protein level
in blood
11. Case 2 - UTI
o Disorders causes destruction of
11 | P a g e
RBC’s
o Inflammation
o Vaginal secretion that get into
urine
Glucose:
Not normally present in urine
When present, called: glucosuria
Results from:
1) Excessive high glucose level in
blood, diabetes militus
2) Reduction in renal threshold, normal
pregnancy and glucosuria
Ketons:
Not normally found in urine
o Intermediate products of fat
metabolism
Present in high amounts, called:
ketonuria
Can be an early indication of insufficient
insulin
Causes:
o Diabetic ketoacidosis
o Starvation
o Ketogenic diets
o Severe exercise
o Exposure to cold
o Carbohydrates loss, (frequent
vomitting)
Test only detects acetone and AcAc (not
β-OHB)
Blood:
Always pathologic in urine
Sometimes chemically can be negative,
but microscopically found positive
o When it happens
We test for ascorbic acid (
vitamin C)
It results into falsely low,
or falsely negative
High levels are called:
o Hemoglobinuria
12. Case 2 - UTI
12 | P a g e
o Hematuria
o Or Myoglobinuria
Underlying causes:
o Intravascular haemolytic anaemia
o Renal calculus
o Infection
o Cancer
o Crush injuries
Discussed later in more details, under
Haematouria section
Leukocyte esterase:
An enzyme present in WBC’s
Normally there are few WBC’s in urine
o High levels, will result in this
screening test positive
Presence of esterase in neutrophils
(pryuria)
Sterile pryuria (neutrophils present but
negative standard urine culture)
Underlying causes:
o Infection
o Chlamydia trachomatis urithritis
o Renal tuberclusis
Nitrite:
Bacteria convert nitrate into nitrite in
urine
When bacteria present, they cause UTI,
leading to increase of nitrites
Postive test is an indication of UTI
Underlying cause:
o Nitrate reducing uropathogens
ex- E.coli
Billirubin:
Not normal present
Produced by liver from haemoglobin of
dead circulating RBcs
When present, called: Bilirubinuria
Underlying cause:
o Viral hepatitis
o Obstructive jaundice
Urobilonogen:
Present in urine in low concentration
o Derivavitive of bilirubin
13. Case 2 - UTI
13 | P a g e
Underlying causes:
o Obstructive jaundice
o Viral hepatitis
o Extravascular haemolytic anemia
(e.g., spherocytosis)
iii. Microscopic examination:
o Cells:
Bacteria
Red blood cells (hematuria)
Neutrophils (pyuria)
Oval fat bodies
Underlying causes:
o UTI (commonly)
o Renal stones
o Cancers (bladder, renal)
o Infection
o Benign prostatic hyperplasia
o Sterile pyuria
o Renal tubular cells with lipid
(nephrotic syndrome)
o Casts
Hyaline
RBC’s
WBC’s
Renal tubular cell
Fatty
Waxy (refactile, acellular)
Haematuria
o Definition:
More than three red blood corpuscles are found in centrifuged urine
per high power field microscopy (>3RBC/HP).
Aetiology:
i. Diseases of urinary system (most common cause)
o Vascular
arteriovenous malformation
arterial emboli or thrombosis
arteriovenous fistular
nutcracker syndrome
renal vein thrombosis
loin-pain hematuria syndrom
coagulation abnormality
excessive anticoagulation
o Glomerular
14. Case 2 - UTI
IgA nehropathy
thin basement membrane disease (Alport
14 | P a g e
syndrome)
other causes of primary and secondary
glomerulonephritis
o Interstitial
allergic interstitial nephritis
analgesic nephropathy
renal cystic diseases
acute pyelonephritis
tuberculosis
renal allograft rejection
o Uroepithelium
malignancy
vigorous excise
trauma
papillary necrosis
cystitis/urethritis/prostatitis (usually caused by
infection)
parasitic diseases (e.g. schistosomiasis)
nephrolithiasis or bladder calculi
o Multiple sites or source unknown
Hypercalciuria
ii. System disorders:
o Haematological disorders:
aplastic anemia
leukemia
allergic purpura
hemophilia
ITP (idiopathy thrombocytopenic purpura)
o Infection:
infective endocarditis
septicemia
epidemic hemorrhagic fever (Hantaan virus)
scarlet fever (-hemolytic streptococcus)
leptospirosis (leptospire)
filariasis (Wuchereria bancrofti, Brugia malayi)
o Connective tissue diseases
systemic lupus erythematous (SLE)
polyarthritis nodosa
o Cardiovascular diseases
15. Case 2 - UTI
15 | P a g e
hypertensive nephropathy
chronic heart failure
renal artery sclerosis
o Endocrine and metabolism diseases
gout
diabetes mellitus
iii. Diseases of adjacent organs to urinary tract
o Appendicitis
o salpingitis
o carcinoma of the rectum
o carcinoma of the colon
o uterocervical cancer
iv. Drug and chemical agents
o Sulfanilamides
o anticoagulation
o cyclophosphamide (CTX)
o mannito
v. miscellaneous
o exercise
o “idopathic” hematuria
Clinical Features:
i. Colour:
o Depends on
amount of RBC’s in urine
Ph value
Normal:
o Yellow colour
o 6.5
ii. pH:
o Acidic: more darker (brown or black)
o Alkaline: red
16. Case 2 - UTI
Red urine, indicative of its alkalinity Dark urine, indicative of its acidity
16 | P a g e
A) Red cast in urine B) RBC’s in urine
17. Case 2 - UTI
17 | P a g e
Drugs:
o Fluroquinolones:
1st generation: - Nalidxic acid
2nd generation :
i. Aprofloxicin
ii. Norfloxicin
iii. Ofloxoicin
3rd generation: larofloxicin
4th generation: Moxifloxacin
Fatal
Have broad spectrum activity (gram (+) , and gram (-))
Inhibit DNA replication by interfering with Topoisomerase II, IV
Drug of Choice:
o For resistant tuberclusis patient
o Isoniazid:
Prodrug that must be activated by bacterial catalylase
o Enzyme present in M. TB
o Known as kat G.
o Form a complex inhibits fatty acid synthesis
Decreases synthesised mycolic acid
No bacterial wall
o Side effects:
Rash
18. Case 2 - UTI
18 | P a g e
Hepatitis
Anemia
Peripheral neuropathy
Mild CNS disturbances
o Rifampin:
Inhibit DNA dependant RNA polymerase
o By binding to B-subunit of RNA
o Prevents transcription to RNA
o Thus, no translation to proteins
Side effects:
i. Hepatotoxicity (most common)
ii. Respiratory distress
iii. Abdominal pain
iv. Nausea
v. Vomitty
vi. Cramps
vii. Diarrhoae
viii. Flue-like syndrome
o Pyrazinamide:
Prodrug that is a activated by pyrazanmaidase
Present in M. Tuberclosis
Forms pyrozonic acid
Inhibits FAS
Distubes bacterial wall
Side effects:
i. Most common: arthlagia
ii. Most severe: hepatotoxicity
o Ethambatol:
Bacteriostatic
o Obstruct of cell wall synthesis (TB)
o Disturbs arabinogalactin synthesis
By inhibiting arabynosyl transeferase
Important in bacterial
wall synthesis
References:
o Robbins
o http://medsci.indiana.edu
o Up-to-date
o http://www.edrep.org
o http://acutemed.co.uk
o http://en.diagnosispro.com/
o http://www.nlm.nih.gov
o http://jfponline.com